Reprint

Opioids and Their Receptors

Present and Emerging Concepts in Opioid Drug Discovery II

Edited by
May 2022
260 pages
  • ISBN978-3-0365-4352-9 (Hardback)
  • ISBN978-3-0365-4351-2 (PDF)

This book is a reprint of the Special Issue Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II that was published in

Chemistry & Materials Science
Medicine & Pharmacology
Summary

Few neurotransmitter systems have fascinated as much as the opioid system (i.e., opioid ligands and their receptors). Over the years, scientific studies of the endogenous opioid system have uncovered a complex and subtle system that exhibits impressive diversity, based on its critical role in modulating a large number of sensory, motivational, emotional and cognitive functions. Additionally, its important therapeutic value for the treatment of many human disorders, including pain, affective and addictive disorders, and gastrointestinal motility disorders, has been of persistent interest. This book specifically covers a broad area of the opioid research, offering up-to-date and new perspectives about opioid drug discovery. The diversity among the discussed topics ranging from medicinal chemistry to opioid pharmacology, from basic science to translational research, is a testimony to the complexity of the opioid system that results from the expression, regulation and functional role of opioid ligands and their receptors. This book will serve as a useful reference to scientists while also stimulating continuous research in the chemistry and pharmacology of the opioid system, with the prospective for finding improved therapies of human diseases where the opioid system plays a central role.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
thiazole; piperazine; tail-clip; hot-plate; acetic acid-induced writhing test; opioid; prodynorphin; epigenetics; transcription; human brain; morphine dosing; behavior; locomotor activity; tolerance; µ-opioid receptor; DAMGO; SR-17018; buprenorphine; nalbuphine; kappa opioid receptor agonist; pruritis; scratching; mice; TAT-HIV; cholestasis; chloroquine; deoxycholic acid; analgesic; δ opioid receptor; G-protein-biased agonist; opioid peptide; rubiscolins; µ-opioid analgesics; angiotensin receptors; chronic pain; neuropathic pain; delta opioid receptor; inverse agonist; irreversible antagonist; non-competitive antagonist; molecular pharmacology; free fatty acid receptors; lipids; opioid receptor; DAMGO; colitis; chemotype; high-throughput screen; delta opioid receptor; allosteric modulation; beta-arrestin; molecular dynamics; opioid receptors; β-amino acids; peptide synthesis; receptor binding studies; functional assay; nociceptin/orphanin FQ receptor; NOP receptor; ligands; opioid receptor; nociceptin; N/OFQ; analgesia; GPCR; opioid receptor; HS-731; peripheral opioid agonist; analgesia; binding; selectivity; molecular docking; molecular dynamics simulations; n/a; chronic pain; fluorescence cross-correlation spectroscopy (FCCS); G protein-coupled receptor (GPCR); opioid; serotonin; n/a